Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Triple-Negative Breast Carcinoma; Metastatic Urothelial Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Stage IV Lu ng Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8 Interventions: Drug: Atezolizumab; Drug: Cyclophosphamide; Drug: Fludarabine; Biological: MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells; Biological: PD1 Inhibitor Sponsors: Fred Hutchinson Cancer Research Center; SignalOne Bio, Inc. Not yet recruiting (Source: Clinica lTrials.gov)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.